SAFETY AND IMMUNOGENICITY OF COMBINED RABIES AND TYPHOID-FEVER IMMUNIZATION

被引：6

作者：

FRITZELL, C

ROLLIN, PE

TOUIR, M

SUREAU, P

TEULIERES, L

机构：

[1] HOP INST PASTEUR,CTR ANTIRABIQUE,25 RUE DOCTEUR ROUX,F-75015 PARIS,FRANCE

[2] PASTEUR MERIEUX SERUMS & VACCINS,F-92430 MARNES COQUETTE,FRANCE

来源：

VACCINE | 1992年 / 10卷 / 05期

关键词：

RABIES; TYPHOID FEVER; COMBINED IMMUNIZATION; IMMUNOGENICITY; SIDE EFFECTS;

D O I：

10.1016/0264-410X(92)90366-R

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The prevalence of rabies and typhoid fever in many developing countries poses a serious health hazard to travellers. The development of a combined immunization schedule would be advantageous. A study was performed on 104 adult volunteers using purified Vero cell rabies vaccine and Typhim Vi, a purified capsular polysaccharide, either separately or in combination. No significant difference was observed in immunogenicity or tolerance between the two groups. A 3-year follow-up study is planned.

引用

页码：299 / 300

页数：2

共 10 条

[1] PREVENTION OF TYPHOID-FEVER IN NEPAL WITH THE VI CAPSULAR POLYSACCHARIDE OF SALMONELLA-TYPHI - A PRELIMINARY-REPORT [J].